Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Effect van maraviroc en/of metformine op levervetfractie bij hiv-geïnfecteerde volwassenen
nov 2024 | Hepatologie, HIV, Virale infecties